Advertisement
Journal Home
Search for

Volume 34, Issue 1, Pages 47-50 (January 2006)


View previous. 11 of 22 View next.

Focal Glucose Hypermetabolism in Interictal State of West Syndrome

Tomohiro Kumada, MD, Hidehiko Okazawa, MD, PhD, Hiroshi Yamauchi, MD, PhD, Toshiyuki Kitoh, MD, PhD, Masatoshi Ito, MD, PhDCorresponding Author Informationemail address

Received 21 December 2004; accepted 25 May 2005.

This report concerns two siblings from a tetrad, both of whom had West syndrome with atypical findings on positron emission tomography using [18F] fluorodeoxyglucose. One manifested periventricular leukoencephalopathy, and the other had periventricular leukoencephalopathy as well as porencephaly because of fetal distress and brain parenchymal hemorrhage in the neonatal period. They developed West syndrome at the age of 9 months. Fluorodeoxyglucose–positron emission tomography study performed after cessation of their seizures revealed an increase in glucose metabolism. The corresponding region presented low-level accumulation in [11C]flumazenil positron emission tomography. The patients remained seizure-free for more than 1 month, and their electroencephalograms only occasionally disclosed sporadic paroxysmal discharges. Because of the decreased density of benzodiazepine receptor in these lesions, the activity of the excitatory neuron system may overexpress that of the inhibitory neuron system, thus resulting in epileptogenesis of the lesions. It is suggested that fluorodeoxyglucose and flumazenil–positron emission tomography revealed functional abnormalities and that epileptogenesis of these patients is still active even when the patient is seizure-free and there are mild epileptogenic discharges on electroencephalogram.

 Department of Pediatrics, Shiga Medical Center for Children, Moriyama, Japan

 Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan

 PET Unit, Research Institute, Shiga Medical Center, Moriyama, Japan

Corresponding Author InformationCommunications should be addressed to: Dr. M. Ito; Department of Pediatrics; Shiga Medical Center for Children; 5-7-30 Moriyama, Moriyama, 524-0022 Japan

PII: S0887-8994(05)00279-1

doi:10.1016/j.pediatrneurol.2005.05.019


View previous. 11 of 22 View next.

Advertisement